Boston Scientific Corpora... (BSX)
99.29
0.39 (0.39%)
At close: Mar 18, 2025, 3:59 PM
99.18
-0.12%
After-hours: Mar 18, 2025, 08:00 PM EDT
0.39% (1D)
| Bid | 98.68 |
| Market Cap | 146.53B |
| Revenue (ttm) | 16.79B |
| Net Income (ttm) | 1.85B |
| EPS (ttm) | 1.25 |
| PE Ratio (ttm) | 79.43 |
| Forward PE | 36.41 |
| Analyst | Buy |
| Ask | 99.67 |
| Volume | 4,283,865 |
| Avg. Volume (20D) | 6,829,872 |
| Open | 98.36 |
| Previous Close | 98.90 |
| Day's Range | 97.94 - 99.41 |
| 52-Week Range | 66.80 - 107.17 |
| Beta | 0.77 |
About BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization th...
Industry Medical - Devices
Sector Healthcare
IPO Date May 19, 1992
Employees 53,000
Stock Exchange NYSE
Ticker Symbol BSX
Website https://www.bostonscientific.com
Analyst Forecast
According to 23 analyst ratings, the average rating for BSX stock is "Buy." The 12-month stock price forecast is $110, which is an increase of 10.79% from the latest price.
Stock ForecastsNext Earnings Release
Boston Scientific Corporation is scheduled to release its earnings on Apr 23, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+1.38%
Boston Scientific shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
+4.3%
Boston Scientific shares are trading higher after the company announced it entered into a definitive deal to acquire Bold Medical.
